Philip F Halloran
Halloran, Philip Francis
Halloran, Philip F.
VIAF ID: 16401478 (Personal)
Permalink: http://viaf.org/viaf/16401478
Preferred Forms
-
-
-
- 100 1 0 ‡a Halloran, Philip F.
-
- 100 1 _ ‡a Halloran, Philip F.
- 100 1 _ ‡a Halloran, Philip Francis
- 100 0 _ ‡a Philip F Halloran
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
General pathology | |
Many forms of renal injury induce a stereotyped response with increased expression of MHC, IFN-gamma, and adhesion molecules | |
The mechanism of action of cyclosporine: A perspective for the 90's | |
Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR. | |
MHC expression in organ transplants: lessons from the knock-out mice | |
Microarrays and transcriptome analysis in renal transplantation. | |
Microcirculation lesions alone are not reliable for identifying antibody-mediated rejection | |
A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression. | |
A molecular classifier for predicting future graft loss in late kidney transplant biopsies | |
Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts | |
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors | |
Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. | |
Molecular patterns in human ulcerative colitis and correlation with response to infliximab | |
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. | |
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables | |
Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas | |
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study | |
Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants | |
Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator. | |
Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups | |
Mycophenolate mofetil reduces production of interferon-dependent major histocompatibility complex induction during allograft rejection, probably by limiting clonal expansion. | |
The nature of biopsies with "borderline rejection" and prospects for eliminating this category | |
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. | |
A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity | |
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure | |
Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997). | |
Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study | |
Pc Receptors and Ia Antigens | |
Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy | |
Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients | |
Possible association of donor blood group A with higher alloantibody responses after renal transplantation | |
Precision Diagnostics in Transplantation: From Bench to Bedside | |
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis | |
The puzzling role of CXCR3 and its ligands in organ allograft rejection | |
Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice | |
Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study. | |
Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens | |
Reduced exposure to calcineurin inhibitors in renal transplantation | |
Reduction of hypoxia-inducible heme oxygenase-1 in the myocardium after left ventricular mechanical support. | |
Relationships among injury, fibrosis, and time in human kidney transplants. | |
Review: The transcripts associated with organ allograft rejection. | |
The role of B cells and alloantibody in the host response to human organ allografts | |
The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney | |
Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts | |
Sirolimus and cyclosporin for renal transplantation | |
The stability of the glomerular filtration rate after renal transplantation is improving | |
Superiority of virtual microscopy versus light microscopy in transplantation pathology | |
SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. | |
Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients | |
Tailoring therapy: balancing toxicity and chronic allograft dysfunction | |
Therapeutic monitoring of mycophenolic acid. A consensus panel report | |
TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury | |
Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. | |
Tolerance versus immunosuppression: a perspective | |
Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection. | |
Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling | |
Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. | |
The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. | |
The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells. | |
The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function | |
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | |
Transplantation immunology, 1989 | |
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence | |
Uniform clinical trial registration policy for journals of kidney diseases, dialysis, and transplantation | |
The unique role of interferon-gamma in the regulation of MHC expression on arterial endothelium | |
An update on risk evaluation and mitigation strategies in transplantation | |
Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. | |
Use of cardioprotective medications in kidney transplant recipients. | |
Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection. | |
Vascularized limb transplantation in the rat. II. Results with allogeneic grafts |